QuikMedic and WellBe Grow Partnership Nationally
"Over the last two years, QuikMedic has served as a natural extension to our home-based primary care team through a dedicated workforce and under jointly developed clinical protocols" shared Dr.
The joint expansion will soon include QuikMedic's first market launch in
"This deepening relationship with WellBe is a testament of QuikMedic's proven and scalable model with like-minded partner groups" says
QuikMedic has become a leading national player setting the gold standard for mobile health solutions through long-term high-value partnerships nationwide.
About WellBe Senior Medical
WellBe Senior Medical works with health plans to provide home-based medical care (HBMC) to patients who are facing multiple complex health challenges. WellBe's providers are committed to providing personalized CompleteCare™ wherever our patients call home. Our care team works together with patients, their caregivers, and physicians to nurture all aspects of health. For more information, or to see if you or a loved one is eligible to receive care from WellBe Senior Medical please visit wellbe.com or call 1-855-493-5523.
About QuikMedic
QuikMedic offers healthcare providers the ability to extend their care services outside the walls of their practice to deliver reliable high-quality urgent and longitudinal care for at-risk patients. The QuikMedic Mobile Care platform enables providers to respond to urgent & emergent patient needs by deploying highly trained Licensed Practical Nurses and Community Paramedics (known as "QuikMedics") to provide in-person care under physician-directed protocols and telehealth-enabled medical control.
View original content to download multimedia:https://www.prnewswire.com/news-releases/quikmedic-and-wellbe-grow-partnership-nationally-302112020.html
SOURCE QuikMedic
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
- NU E Power Corp. Files 2026 First Quarter Results
- TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share